Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Sangart initiates phase IIa study of oxygen therapeutic agent MP-4OX

Dec. 11, 2009

Banyu presents MCH-R1 antagonists for treatment of obesity and diabetes

Dec. 11, 2009

Novel PHD inhibitors presented by Janssen for anemia therapy

Dec. 11, 2009

Novel glucokinase activators discovered at Takeda

Dec. 11, 2009

Neurocrine reports results from phase II trial of elagolix in endometriosis

Dec. 11, 2009

Vissane approved in Europe for endometriosis

Dec. 10, 2009

Pharming completes pre-BLA meeting with FDA for Rhucin in hereditary angioedema

Dec. 10, 2009

Bayer Schering Pharma claims novel HIF prolyl hydroxylase inhibitors

Dec. 10, 2009

Novel GK activators claimed by Roche as antidiabetic agents

Dec. 9, 2009

Takeda discloses novel ACC inhibitors for the treatment of obesity

Dec. 9, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...